Response rates to chemotherapy are good and in some trials compare favorably with radiation. Reduce symptomatic mass effect. Ommaya resevoir insertion. Average survival for untreated patients is 1.5 months. There are no cures.
All patients die of their disease.
Average survival with treatment depends on lymphoma type. Patients with systemic lymphomas of the same histological variety survive longer. Median survival time for AIDS patients treatment is 1.5-3 months. Median survival for favorable solitary lesions documented up to 45 months. With primary chemotherapy the rates are lower but the follow up is shorter.